Exact Mass: 337.141

Exact Mass Matches: 337.141

Found 175 metabolites which its exact mass value is equals to given mass value 337.141, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Linezolid

N-{[(5S)-3-[3-fluoro-4-(morpholin-4-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl}acetamide

C16H20FN3O4 (337.1438)


Linezolid is only found in individuals that have used or taken this drug. It is a synthetic antibiotic, the first of the oxazolidinone class, used for the treatment of infections caused by multi-resistant bacteria including streptococcus and methicillin-resistant Staphylococcus aureus (MRSA). Linezolid is a synthetic antibacterial agent of the oxazolidinone class of antibiotics. It has in vitro activity against aerobic Gram positive bacteria, certain Gram negative bacteria and anaerobic microorganisms. It selectively inhibits bacterial protein synthesis through binding to sites on the bacterial ribosome and prevents the formation of a functional 70S-initiation complex. Specifically, linezolid binds to a site on the bacterial 23S ribosomal RNA of the 50S subunit and prevents the formation of a functional 70S initiation complex, which is an essential component of the bacterial translation process. The results of time-kill studies have shown linezolid to be bacteriostatic against enterococci and staphylococci. For streptococci, linezolid was found to be bactericidal for the majority of strains. Linezolid is also a reversible, nonselective inhibitor of monoamine oxidase. Therefore, linezolid has the potential for interaction with adrenergic and serotonergic agents. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D000890 - Anti-Infective Agents > D023303 - Oxazolidinones C254 - Anti-Infective Agent > C258 - Antibiotic

   

Streptobiosamine

Streptobiosamine

C13H23NO9 (337.1373)


An amino disaccharide that is a 2-deoxy-2-(methylamino)-alpha-L-glucopyranose ring joined to a L-lyxose with a formyl substituent at position 3.

   
   

Ficine

4H-1-Benzopyran-4-one, 5,7-dihydroxy-8-(1-methyl-2-pyrrolidinyl)-2-phenyl-, (-)-

C20H19NO4 (337.1314)


   

Isoficine

4H-1-Benzopyran-4-one, 5,7-dihydroxy-6-(1-methyl-2-pyrrolidinyl)-2-phenyl-

C20H19NO4 (337.1314)


   

Talampanel

Talampanel

C19H19N3O3 (337.1426)


C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant Same as: D02696 Talampanel (LY300164) is an orally and selective α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptor antagonis with anti-seizure activity[1]. Talampanel (IVAX) has neuroprotective effects in rodent stroke models[2]. Talampanel attenuates caspase-3 dependent apoptosis in mouse brain[2].

   

fuchsin basic

Fuchsine base monohydrochloride

C20H20ClN3 (337.1346)


D004396 - Coloring Agents > D012394 - Rosaniline Dyes

   

Lambertine

16,17-dimethoxy-5,7-dioxa-13-azapentacyclo[11.8.0.0^{2,10}.0^{4,8}.0^{15,20}]henicosa-1(21),2(10),3,8,15,17,19-heptaene

C20H19NO4 (337.1314)


Lambertine is an alkaloid. Dihydroberberine is a natural product found in Thalictrum foliolosum, Berberis vulgaris, and other organisms with data available. Lambertine is found in fruits. Lambertine is an alkaloid from Berberis vulgaris (barberry). Alkaloid from Berberis vulgaris (barberry). Lambertine is found in tea and fruits.

   

Junosidine

2,11-Dihydro-5-hydroxy-10-methoxy-2,2,11-trimethyl-6H-pyrano[3,2-b]acridin-6-one, 9ci

C20H19NO4 (337.1314)


Junosidine is a member of the class of compounds known as acridones. Acridones are acridines containing a ketone group attached to the C9 carbon atom of the acridine moiety. Junosidine is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Junosidine is an alkaloid that has been found in the root bark of Citrus junos (yuzu).

   

5-Methoxynoracronycine

11-hydroxy-6-methoxy-2,2,5-trimethyl-5,10-dihydro-2H-1-oxa-5-azatetraphen-10-one

C20H19NO4 (337.1314)


5-Methoxynoracronycine is found in citrus. 5-Methoxynoracronycine is an alkaloid from the bark of Citrus junos (yuzu

   

4-O-alpha-D-Galactopyranosylcalystegine B2

4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-8-azabicyclo[3.2.1]octane-1,2,3-triol

C13H23NO9 (337.1373)


4-O-alpha-D-Galactopyranosylcalystegine B2 is found in fruits. 4-O-alpha-D-Galactopyranosylcalystegine B2 is an alkaloid from the fruit of Morus alba (white mulberry). Alkaloid from the fruit of Morus alba (white mulberry). 4-O-alpha-D-Galactopyranosylcalystegine B2 is found in fruits.

   

6-oxo-famciclovir

2-[(acetyloxy)methyl]-4-(6-hydroxy-2-imino-3,9-dihydro-2H-purin-9-yl)butyl acetate

C14H19N5O5 (337.1386)


6-oxo-famciclovir is a metabolite of famciclovir. Famciclovir is a guanine analogue antiviral drug used for the treatment of various herpesvirus infections, most commonly for herpes zoster (shingles). It is a prodrug form of penciclovir with improved oral bioavailability. Famciclovir is marketed under the trade name Famvir. On August 24, 2007, the United States Food and Drug Administration approved the first generic version of famciclovir. (Wikipedia)

   

1-(4-Aminophenyl)-3-acetyl-4-methyl-3,4-dihydro-7,8-methylenedioxy-5H-2,3-benzodiazepine

1-[10-(4-aminophenyl)-13-methyl-4,6-dioxa-11,12-diazatricyclo[7.5.0.0^{3,7}]tetradeca-1,3(7),8,10-tetraen-12-yl]ethan-1-one

C19H19N3O3 (337.1426)


   

N(6)-Monobutyryladenosine

N-{9-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-9H-purin-6-yl}butanamide

C14H19N5O5 (337.1386)


   

Satigrel

4-Cyano-5,5-bis(4-methoxyphenyl)-4-pentenoic acid

C20H19NO4 (337.1314)


   

Ractopamine hydrochloride

4-Hydroxy-alpha-(((3-(4-hydroxyphenyl)-1-methylpropyl)amino)methyl)benzenemethanol

C18H24ClNO3 (337.1445)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists Leanness enhancer for pigs. Approved for use in the USA

   

Voxelotor

2-hydroxy-6-({2-[1-(propan-2-yl)-1H-pyrazol-5-yl]pyridin-3-yl}methoxy)benzaldehyde

C19H19N3O3 (337.1426)


   
   
   

Murrayamine I

Murrayamine I

C20H19NO4 (337.1314)


   

Dehydrocrebanine

Dehydrocrebanine

C20H19NO4 (337.1314)


   

Dehydrodicentrine

5H-Benzo[g]-1,3-benzodioxolo[6,5,4-de]quinoline, 6,7-dihydro-10,11-dimethoxy-7-Methyl-

C20H19NO4 (337.1314)


   

AKOS000277823

AKOS000277823

C20H19NO4 (337.1314)


   

Sinomendine

Sinomendine

C20H19NO4 (337.1314)


An aporphine alkaloid that is 7-methyldibenzo[de,g]quinolin-7-ol carrying three additional methoxy substituents at positions 2, 8 and 9.

   

Dehydronantenine

Dehydronantenine

C20H19NO4 (337.1314)


   

N-Acetylxylopine

N-Acetylxylopine

C20H19NO4 (337.1314)


   
   
   
   

3,9,10-trimethoxy-5,6-dihydroisoquinolin[2,1-b]isoquinolin-7-ium-2-olate

3,9,10-trimethoxy-5,6-dihydroisoquinolin[2,1-b]isoquinolin-7-ium-2-olate

C20H19NO4 (337.1314)


   
   

SCHEMBL22015730

SCHEMBL22015730

C20H19NO4 (337.1314)


   

2-O-Methyl-b-D-N-acetylneuraminic acid methyl ester

2-O-Methyl-b-D-N-acetylneuraminic acid methyl ester

C13H23NO9 (337.1373)


   

SCHEMBL4265170

SCHEMBL4265170

C13H23NO9 (337.1373)


   

(-)-N-Acetylnorstephalagine|N-Acetylnorstephalagin|N-acetylnorstephalagine

(-)-N-Acetylnorstephalagine|N-Acetylnorstephalagin|N-acetylnorstephalagine

C20H19NO4 (337.1314)


   

(+)-N-acetylnornuciferine

(+)-N-acetylnornuciferine

C20H19NO4 (337.1314)


   
   
   
   

N,O-Didemethylbuchenavianine

N,O-Didemethylbuchenavianine

C20H19NO4 (337.1314)


   
   

6-Acetyl-7-methoxy-1,2-(methylenedioxy)-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline

6-Acetyl-7-methoxy-1,2-(methylenedioxy)-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline

C20H19NO4 (337.1314)


   

N-Demethylcapitavine

N-Demethylcapitavine

C20H19NO4 (337.1314)


   

Dehydroformouregine

Dehydroformouregine

C20H19NO4 (337.1314)


   
   

(6,7-dimethoxy-4-methylisoquinolinyl)-(4-methoxyphenyl)-methanone

(6,7-dimethoxy-4-methylisoquinolinyl)-(4-methoxyphenyl)-methanone

C20H19NO4 (337.1314)


   

(-)-N-acetylxylopine|6-Acetyl-9-methoxy-1,2-methylendioxy-6abeta-aporphan|6-acetyl-9-methoxy-1,2-methylenedioxy-6abeta-aporphane|N-acetylxylopine

(-)-N-acetylxylopine|6-Acetyl-9-methoxy-1,2-methylendioxy-6abeta-aporphan|6-acetyl-9-methoxy-1,2-methylenedioxy-6abeta-aporphane|N-acetylxylopine

C20H19NO4 (337.1314)


   

Acronicine epoxide

Acronicine epoxide

C20H19NO4 (337.1314)


   

Pseudojatrorrhizine

Pseudojatrorrhizine

C20H19NO4 (337.1314)


   

Linezolid

Linezolid (Zyvox)

C16H20FN3O4 (337.1438)


J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D000890 - Anti-Infective Agents > D023303 - Oxazolidinones C254 - Anti-Infective Agent > C258 - Antibiotic CONFIDENCE standard compound; EAWAG_UCHEM_ID 3291

   

N2-Isobutyryl-2-deoxyguanosine

N2-Isobutyryl-2-deoxyguanosine

C14H19N5O5 (337.1386)


relative retention time with respect to 9-anthracene Carboxylic Acid is 0.589 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.591 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.583 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.587

   
   
   

N2-Isobutyl-deoxyguanosine

N2-Isobutyl-deoxyguanosine

C14H19N5O5 (337.1386)


   

N2-(S)-Propano-deoxyguanosine

N2-(S)-Propano-deoxyguanosine

C14H19N5O5 (337.1386)


   

N2-(R)-Propano-deoxyguanosine

N2-(R)-Propano-deoxyguanosine

C14H19N5O5 (337.1386)


   

Dextrorphan sulfate

Dextrorphan sulfate

C17H23NO4S (337.1348)


   

Zolpidem Metabolite I

Zolpidem Metabolite I

C19H19N3O3 (337.1426)


   

Zolpidem Metabolite II

Zolpidem Metabolite II

C19H19N3O3 (337.1426)


   

(S)-cis-N-Methylstylopine

(S)-cis-N-Methylstylopine

C20H19NO4 (337.1314)


   
   

5-Methoxynoracronycine

11-hydroxy-6-methoxy-2,2,5-trimethyl-5,10-dihydro-2H-1-oxa-5-azatetraphen-10-one

C20H19NO4 (337.1314)


   

Junosidine

2,11-Dihydro-5-hydroxy-10-methoxy-2,2,11-trimethyl-6H-pyrano[3,2-b]acridin-6-one, 9ci

C20H19NO4 (337.1314)


   

Lambertine

16,17-dimethoxy-5,7-dioxa-13-azapentacyclo[11.8.0.0^{2,10}.0^{4,8}.0^{15,20}]henicosa-1(21),2(10),3,8,15,17,19-heptaene

C20H19NO4 (337.1314)


   

4-O-a-D-Galactopyranosylcalystegine b2

4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-8-azabicyclo[3.2.1]octane-1,2,3-triol

C13H23NO9 (337.1373)


   
   
   

Satigrel

4-cyano-5,5-bis(4-methoxyphenyl)pent-4-enoic acid

C20H19NO4 (337.1314)


C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors

   

Fmoc-D-Cyclopropylglycine

Fmoc-D-Cyclopropylglycine

C20H19NO4 (337.1314)


   
   

1-[CARBOXY-(4-METHYLSULFANYL-PHENYL)-METHYL]-PIPERIDINE-3-CARBOXYLICACIDETHYLESTER

1-[CARBOXY-(4-METHYLSULFANYL-PHENYL)-METHYL]-PIPERIDINE-3-CARBOXYLICACIDETHYLESTER

C17H23NO4S (337.1348)


   

1-FMOC-PYRROLIDINE-3-CARBOXYLIC ACID

1-FMOC-PYRROLIDINE-3-CARBOXYLIC ACID

C20H19NO4 (337.1314)


   

AT7867

4-(4-chlorophenyl)-4-[4-(1H-pyrazol-4-yl)phenyl]piperidine

C20H20ClN3 (337.1346)


AT7867 is a potent ATP-competitive inhibitor of Akt1/Akt2/Akt3 and p70S6K/PKA with IC50s of 32 nM/17 nM/47 nM and 85 nM/20 nM, respectively.

   

Fmoc-L-Cyclopropylglycine

Fmoc-L-Cyclopropylglycine

C20H19NO4 (337.1314)


   

(R)-N-Fmoc-Allylglycine

(R)-N-Fmoc-Allylglycine

C20H19NO4 (337.1314)


   
   

Fmoc-1-amino-1-cyclobutanecarboxylic acid

Fmoc-1-amino-1-cyclobutanecarboxylic acid

C20H19NO4 (337.1314)


   

Fmoc-D-Pro-OH

Fmoc-D-Pro-OH

C20H19NO4 (337.1314)


   

2-Naphthalenol,1-[phenyl[(phenylmethylene)amino]methyl]-

2-Naphthalenol,1-[phenyl[(phenylmethylene)amino]methyl]-

C24H19NO (337.1467)


   

(S)-N-Fmoc-Allylglycine

(S)-N-Fmoc-Allylglycine

C20H19NO4 (337.1314)


   

Benzyl 1-oxo-3-phenyl-2-oxa-5-azaspiro[3.4]octane-5-carboxylate

Benzyl 1-oxo-3-phenyl-2-oxa-5-azaspiro[3.4]octane-5-carboxylate

C20H19NO4 (337.1314)


   

Dobutamine hydrochloride

Dobutamine hydrochloride

C18H24ClNO3 (337.1445)


D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists C78274 - Agent Affecting Cardiovascular System > C78322 - Cardiotonic Agent D020011 - Protective Agents > D002316 - Cardiotonic Agents D002317 - Cardiovascular Agents Dobutamine hydrochloride is a synthetic catecholamine that acts on α1-AR, β1-AR, β2-AR (α-1, β-1 andβ-2 adrenoceptors). Dobutamine hydrochloride is a selective β1-AR agonist, relatively weak activity at α1-AR and β2-AR. Dobutamine hydrochloride can increase cardiac output and correct hypoperfusion[1][2][3][4].

   

Dizocilpine maleate

Dizocilpine maleate

C20H19NO4 (337.1314)


D018377 - Neurotransmitter Agents > D018683 - Excitatory Amino Acid Agents > D018691 - Excitatory Amino Acid Antagonists D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent D020011 - Protective Agents Dizocilpine maleate (MK-801 maleate) is a potent, selective and non-competitive NMDA receptor antagonist with Kd of 37.2 nM in rat brain membranes.

   
   
   

(-)-Dizocilpine maleate

(-)-Dizocilpine maleate

C20H19NO4 (337.1314)


   

(R)-(+)-trans-4-(1-Aminoethyl)-N-(4-pyridyl)cyclohexanecarboxamide Dihydrochloride Monohydrate

(R)-(+)-trans-4-(1-Aminoethyl)-N-(4-pyridyl)cyclohexanecarboxamide Dihydrochloride Monohydrate

C14H25Cl2N3O2 (337.1324)


   

(R)-3-(3-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-5-(hydroxyMethyl)oxazolidin-2-one

(R)-3-(3-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-5-(hydroxyMethyl)oxazolidin-2-one

C16H21BFNO5 (337.1497)


   

AntioxidantIPPSI

AntioxidantIPPSI

C18H19N5S (337.1361)


   

Fmoc-Cyclopropylglycine

Fmoc-Cyclopropylglycine

C20H19NO4 (337.1314)


   

Voxelotor

Voxelotor

C19H19N3O3 (337.1426)


C78275 - Agent Affecting Blood or Body Fluid B - Blood and blood forming organs D006401 - Hematologic Agents

   

Clenpenterol-D11 hydrochloride

Clenpenterol-D11 hydrochloride

C13H10D11Cl3N2O (337.141)


   

(-)-Dizocilpine

(-)-Dizocilpine

C20H19NO4 (337.1314)


(-)-Dizocilpine maleate ((-)-MK-801 maleate) is a less active (-)-enantiomer of Dizocilpine. (-)-Dizocilpine maleate is a selective and non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist with a Ki of 211.7 nM. (-)-Dizocilpine maleate has antidepressant effects[1][2]. (-)-Dizocilpine maleate ((-)-MK-801 maleate) is a less active (-)-enantiomer of Dizocilpine. (-)-Dizocilpine maleate is a selective and non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist with a Ki of 211.7 nM. (-)-Dizocilpine maleate has antidepressant effects[1][2].

   
   

Isoxsuprine hydrochloride

Isoxsuprine hydrochloride

C18H24ClNO3 (337.1445)


D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D012102 - Reproductive Control Agents > D015149 - Tocolytic Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents Isoxsuprine hydrochloride is a beta-adrenergic receptor agonist with Kis of 13.65 μΜ and 3.48 μΜ for myometrial and placcntal beta-adrenergic receptor, respectively. Isoxsuprine hydrochloride is also a NMDA receptor antagonist.

   

Tecadenoson

Tecadenoson

C14H19N5O5 (337.1386)


D018377 - Neurotransmitter Agents > D058905 - Purinergic Agents > D058913 - Purinergic Agonists C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent Tecadenoson (CVT-510) is a selective A1 adenosine receptor agonist. Tecadenoson (CVT-510) is a selective A1 adenosine receptor agonist.

   

6-oxo-famciclovir

6-oxo-famciclovir

C14H19N5O5 (337.1386)


   

(8-Methyl-8-azabicyclo[3.2.1]octan-3-yl) 2-(4-chlorophenoxy)butanoate

(8-Methyl-8-azabicyclo[3.2.1]octan-3-yl) 2-(4-chlorophenoxy)butanoate

C18H24ClNO3 (337.1445)


   

[4-(Benzenesulfonyl)-1-piperazinyl]-(1-piperidinyl)methanone

[4-(Benzenesulfonyl)-1-piperazinyl]-(1-piperidinyl)methanone

C16H23N3O3S (337.146)


   

N-[(1,2-dimethyl-5-indolyl)methyl]-2-(4-nitrophenyl)acetamide

N-[(1,2-dimethyl-5-indolyl)methyl]-2-(4-nitrophenyl)acetamide

C19H19N3O3 (337.1426)


   

3-[3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-N-(3-methylphenyl)propanamide

3-[3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-N-(3-methylphenyl)propanamide

C19H19N3O3 (337.1426)


   

N-[(1,2-dimethyl-5-indolyl)methyl]-2-methyl-3-nitrobenzamide

N-[(1,2-dimethyl-5-indolyl)methyl]-2-methyl-3-nitrobenzamide

C19H19N3O3 (337.1426)


   
   

Cyclic 1,N(2)-propanodeoxyguanosine

Cyclic 1,N(2)-propanodeoxyguanosine

C14H19N5O5 (337.1386)


   

Ractopamine Hydrochloride

Ractopamine Hydrochloride

C18H24ClNO3 (337.1445)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists

   

2,9,10-Trimethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-3-one

2,9,10-Trimethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-3-one

C20H19NO4 (337.1314)


   

2,3,10-Trimethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-9-one

2,3,10-Trimethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-9-one

C20H19NO4 (337.1314)


   

3-[(3,5-dimethyl-1,2-oxazol-4-yl)methoxy]-N-(3-methylpyridin-2-yl)benzamide

3-[(3,5-dimethyl-1,2-oxazol-4-yl)methoxy]-N-(3-methylpyridin-2-yl)benzamide

C19H19N3O3 (337.1426)


   

7-Hydroxy-8-(4-morpholinylmethyl)-3-phenyl-1-benzopyran-4-one

7-Hydroxy-8-(4-morpholinylmethyl)-3-phenyl-1-benzopyran-4-one

C20H19NO4 (337.1314)


   

4-tert-butyl-N-(1,4-dioxo-2,3-dihydrophthalazin-5-yl)benzamide

4-tert-butyl-N-(1,4-dioxo-2,3-dihydrophthalazin-5-yl)benzamide

C19H19N3O3 (337.1426)


   

2-hydroxy-4-oxo-1-propyl-N-(pyridin-4-ylmethyl)quinoline-3-carboxamide

2-hydroxy-4-oxo-1-propyl-N-(pyridin-4-ylmethyl)quinoline-3-carboxamide

C19H19N3O3 (337.1426)


   

ethyl 3-(1,3-dioxo-1,3,3a,4,7,7a-hexahydro-2H-spiro[2-aza-4,7-methanoisoindole-8,1-cyclopropan]-2-yl)benzoate

ethyl 3-(1,3-dioxo-1,3,3a,4,7,7a-hexahydro-2H-spiro[2-aza-4,7-methanoisoindole-8,1-cyclopropan]-2-yl)benzoate

C20H19NO4 (337.1314)


   

2-amino-4-(2-ethoxyphenyl)-6,7-dimethyl-5-oxo-4H-pyrano[3,2-c]pyridine-3-carbonitrile

2-amino-4-(2-ethoxyphenyl)-6,7-dimethyl-5-oxo-4H-pyrano[3,2-c]pyridine-3-carbonitrile

C19H19N3O3 (337.1426)


   

N-(2-butan-2-ylphenyl)-7-nitro-1H-indole-2-carboxamide

N-(2-butan-2-ylphenyl)-7-nitro-1H-indole-2-carboxamide

C19H19N3O3 (337.1426)


   

2-[[2-(5,6-Dimethyl-1-benzimidazolyl)-1-oxoethyl]amino]benzoic acid methyl ester

2-[[2-(5,6-Dimethyl-1-benzimidazolyl)-1-oxoethyl]amino]benzoic acid methyl ester

C19H19N3O3 (337.1426)


   

N-(2-methoxyethyl)-3-methyl-5H-indazolo[2,3-a][3,1]benzoxazine-9-carboxamide

N-(2-methoxyethyl)-3-methyl-5H-indazolo[2,3-a][3,1]benzoxazine-9-carboxamide

C19H19N3O3 (337.1426)


   

[3-[3-(5-Methyl-2-furanyl)-1,2,4-oxadiazol-5-yl]-1-piperidinyl]-phenylmethanone

[3-[3-(5-Methyl-2-furanyl)-1,2,4-oxadiazol-5-yl]-1-piperidinyl]-phenylmethanone

C19H19N3O3 (337.1426)


   

N-[(2S)-1-hydroxypropan-2-yl]-3-methyl-5H-indazolo[2,3-a][3,1]benzoxazine-9-carboxamide

N-[(2S)-1-hydroxypropan-2-yl]-3-methyl-5H-indazolo[2,3-a][3,1]benzoxazine-9-carboxamide

C19H19N3O3 (337.1426)


   

ethyl N-acetylneuraminate

ethyl N-acetylneuraminate

C13H23NO9 (337.1373)


   

N-[2-(3,4-dihydroxyphenyl)ethyl]-4-(4-hydroxyphenyl)butan-2-aminium chloride

N-[2-(3,4-dihydroxyphenyl)ethyl]-4-(4-hydroxyphenyl)butan-2-aminium chloride

C18H24ClNO3 (337.1445)


   

(2R,3R,4S)-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-3-[4-(3-pyridinyl)phenyl]-2-azetidinecarbonitrile

(2R,3R,4S)-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-3-[4-(3-pyridinyl)phenyl]-2-azetidinecarbonitrile

C19H19N3O3 (337.1426)


   

(2S,3S,4R)-2-cyano-4-(hydroxymethyl)-N-(2-methoxyphenyl)-3-phenyl-1-azetidinecarboxamide

(2S,3S,4R)-2-cyano-4-(hydroxymethyl)-N-(2-methoxyphenyl)-3-phenyl-1-azetidinecarboxamide

C19H19N3O3 (337.1426)


   

(2R,3S,4S)-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-3-[4-(3-pyridinyl)phenyl]-2-azetidinecarbonitrile

(2R,3S,4S)-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-3-[4-(3-pyridinyl)phenyl]-2-azetidinecarbonitrile

C19H19N3O3 (337.1426)


   

(2R,3R,4S)-2-cyano-4-(hydroxymethyl)-N-(2-methoxyphenyl)-3-phenylazetidine-1-carboxamide

(2R,3R,4S)-2-cyano-4-(hydroxymethyl)-N-(2-methoxyphenyl)-3-phenylazetidine-1-carboxamide

C19H19N3O3 (337.1426)


   

(2R,3R,4R)-2-cyano-4-(hydroxymethyl)-N-(2-methoxyphenyl)-3-phenyl-1-azetidinecarboxamide

(2R,3R,4R)-2-cyano-4-(hydroxymethyl)-N-(2-methoxyphenyl)-3-phenyl-1-azetidinecarboxamide

C19H19N3O3 (337.1426)


   

(2R,3S,4R)-2-cyano-4-(hydroxymethyl)-N-(2-methoxyphenyl)-3-phenylazetidine-1-carboxamide

(2R,3S,4R)-2-cyano-4-(hydroxymethyl)-N-(2-methoxyphenyl)-3-phenylazetidine-1-carboxamide

C19H19N3O3 (337.1426)


   

(2S,3R,4R)-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-3-[4-(3-pyridinyl)phenyl]-2-azetidinecarbonitrile

(2S,3R,4R)-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-3-[4-(3-pyridinyl)phenyl]-2-azetidinecarbonitrile

C19H19N3O3 (337.1426)


   

(2S,3S,4R)-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-3-[4-(3-pyridinyl)phenyl]-2-azetidinecarbonitrile

(2S,3S,4R)-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-3-[4-(3-pyridinyl)phenyl]-2-azetidinecarbonitrile

C19H19N3O3 (337.1426)


   

(2R,3S,4S)-2-cyano-4-(hydroxymethyl)-N-(2-methoxyphenyl)-3-phenyl-1-azetidinecarboxamide

(2R,3S,4S)-2-cyano-4-(hydroxymethyl)-N-(2-methoxyphenyl)-3-phenyl-1-azetidinecarboxamide

C19H19N3O3 (337.1426)


   

(2S,3S,4S)-2-cyano-4-(hydroxymethyl)-N-(2-methoxyphenyl)-3-phenyl-1-azetidinecarboxamide

(2S,3S,4S)-2-cyano-4-(hydroxymethyl)-N-(2-methoxyphenyl)-3-phenyl-1-azetidinecarboxamide

C19H19N3O3 (337.1426)


   

(2R,3S,4R)-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-3-[4-(3-pyridinyl)phenyl]-2-azetidinecarbonitrile

(2R,3S,4R)-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-3-[4-(3-pyridinyl)phenyl]-2-azetidinecarbonitrile

C19H19N3O3 (337.1426)


   

(2S,3R,4R)-2-cyano-4-(hydroxymethyl)-N-(2-methoxyphenyl)-3-phenyl-1-azetidinecarboxamide

(2S,3R,4R)-2-cyano-4-(hydroxymethyl)-N-(2-methoxyphenyl)-3-phenyl-1-azetidinecarboxamide

C19H19N3O3 (337.1426)


   

N-hydroxy-N-[(E)-[(2S,3S,4S,5S)-2,3,4,5,6-pentahydroxyhexylidene]amino]hexanediamide

N-hydroxy-N-[(E)-[(2S,3S,4S,5S)-2,3,4,5,6-pentahydroxyhexylidene]amino]hexanediamide

C12H23N3O8 (337.1485)


   

N-hydroxy-N-[(E)-[(2R,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexylidene]amino]hexanediamide

N-hydroxy-N-[(E)-[(2R,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexylidene]amino]hexanediamide

C12H23N3O8 (337.1485)


   

Nonanal O-[(pentafluorophenyl)methyl]oxime

Nonanal O-[(pentafluorophenyl)methyl]oxime

C16H20F5NO (337.1465)


   

4-O-alpha-D-Galactopyranosylcalystegine B2

4-O-alpha-D-Galactopyranosylcalystegine B2

C13H23NO9 (337.1373)


   

N-[[(5S)-3-[3-Fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]-acetamide

N-[[(5S)-3-[3-Fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]-acetamide

C16H20FN3O4 (337.1438)


   

ISAM-140

ISAM-140

C19H19N3O3 (337.1426)


ISAM-140 (22b) is a potent and highly selective A2B adenosine receptor antagonist with a Ki of 3.49 nM[1].

   

10-hydroxy-12-methoxy-2,2,11-trimethyl-1-oxa-11-azatetracen-6-one

10-hydroxy-12-methoxy-2,2,11-trimethyl-1-oxa-11-azatetracen-6-one

C20H19NO4 (337.1314)


   

6,7-dimethoxy-1-(4-methoxybenzoyl)-4-methylisoquinoline

6,7-dimethoxy-1-(4-methoxybenzoyl)-4-methylisoquinoline

C20H19NO4 (337.1314)


   

(1s,24s)-24-methyl-5,7,17,19-tetraoxa-13-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁵,²³.0¹⁶,²⁰]tetracosa-2,4(8),9,15,20,22-hexaene

(1s,24s)-24-methyl-5,7,17,19-tetraoxa-13-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁵,²³.0¹⁶,²⁰]tetracosa-2,4(8),9,15,20,22-hexaene

C20H19NO4 (337.1314)


   

1-[(1s,2r)-1-amino-2-{[(1r,2s)-2-amino-1-hydroxy-2-(4-oxopyridin-1-yl)ethyl](hydroxy)amino}-2-hydroxyethyl]pyridin-4-one

1-[(1s,2r)-1-amino-2-{[(1r,2s)-2-amino-1-hydroxy-2-(4-oxopyridin-1-yl)ethyl](hydroxy)amino}-2-hydroxyethyl]pyridin-4-one

C14H19N5O5 (337.1386)


   

atalaphyllidine; 11,12-n,o-di-me

NA

C20H19NO4 (337.1314)


{"Ingredient_id": "HBIN017269","Ingredient_name": "atalaphyllidine; 11,12-n,o-di-me","Alias": "NA","Ingredient_formula": "C20H19NO4","Ingredient_Smile": "NA","Ingredient_weight": "337.37","OB_score": "NA","CAS_id": "51179-68-1","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "6507","PubChem_id": "NA","DrugBank_id": "NA"}

   

(1r,2s,3r,5s,6r)-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-8-azabicyclo[3.2.1]octane-1,2,6-triol

(1r,2s,3r,5s,6r)-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-8-azabicyclo[3.2.1]octane-1,2,6-triol

C13H23NO9 (337.1373)


   

(9s)-10-acetyl-15,16-dimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaen-8-one

(9s)-10-acetyl-15,16-dimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaen-8-one

C20H19NO4 (337.1314)


   

1-[(12r)-16-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaen-11-yl]ethanone

1-[(12r)-16-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaen-11-yl]ethanone

C20H19NO4 (337.1314)


   

1-[(12s,13r)-13-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaen-11-yl]ethanone

1-[(12s,13r)-13-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaen-11-yl]ethanone

C20H19NO4 (337.1314)


   

16,17-dimethoxy-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,12,14(19),15,17-heptaene

16,17-dimethoxy-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,12,14(19),15,17-heptaene

C20H19NO4 (337.1314)


   

15,16-dimethoxy-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,12,14(19),15,17-heptaene

15,16-dimethoxy-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,12,14(19),15,17-heptaene

C20H19NO4 (337.1314)


   

17-methoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14(19)-hexaen-18-one

17-methoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14(19)-hexaen-18-one

C20H19NO4 (337.1314)


   

(17s)-17-methoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14(19)-hexaen-18-one

(17s)-17-methoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14(19)-hexaen-18-one

C20H19NO4 (337.1314)


   

10-acetyl-15,16-dimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaen-8-one

10-acetyl-15,16-dimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaen-8-one

C20H19NO4 (337.1314)


   

1-{16-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaen-11-yl}ethanone

1-{16-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaen-11-yl}ethanone

C20H19NO4 (337.1314)


   

3,4,11-trimethoxy-7,8-dihydro-6-azatetraphen-10-one

3,4,11-trimethoxy-7,8-dihydro-6-azatetraphen-10-one

C20H19NO4 (337.1314)


   

14,15,16-trimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,13,15-heptaene-10-carbaldehyde

14,15,16-trimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,13,15-heptaene-10-carbaldehyde

C20H19NO4 (337.1314)


   

(1s,24r)-24-methyl-5,7,17,19-tetraoxa-13-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁵,²³.0¹⁶,²⁰]tetracosa-2,4(8),9,15,20,22-hexaene

(1s,24r)-24-methyl-5,7,17,19-tetraoxa-13-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁵,²³.0¹⁶,²⁰]tetracosa-2,4(8),9,15,20,22-hexaene

C20H19NO4 (337.1314)


   

1-{17-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaen-11-yl}ethanone

1-{17-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaen-11-yl}ethanone

C20H19NO4 (337.1314)


   

14,15-dimethoxy-8,8-dimethyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,9(17),10,12,14-octaene-5,16-diol

14,15-dimethoxy-8,8-dimethyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,9(17),10,12,14-octaene-5,16-diol

C20H19NO4 (337.1314)


   

{9-hydroxy-3,5-dimethyl-11h-pyrano[3,2-a]carbazol-3-yl}methyl acetate

{9-hydroxy-3,5-dimethyl-11h-pyrano[3,2-a]carbazol-3-yl}methyl acetate

C20H19NO4 (337.1314)


   

3-methanesulfonyl-n-(2-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}ethyl)prop-2-enimidic acid

3-methanesulfonyl-n-(2-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}ethyl)prop-2-enimidic acid

C17H23NO4S (337.1348)


   

24-methyl-5,7,17,19-tetraoxa-13-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁵,²³.0¹⁶,²⁰]tetracosa-2,4(8),9,15,20,22-hexaene

24-methyl-5,7,17,19-tetraoxa-13-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁵,²³.0¹⁶,²⁰]tetracosa-2,4(8),9,15,20,22-hexaene

C20H19NO4 (337.1314)


   

1-[(12r)-7-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-11-yl]ethanone

1-[(12r)-7-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-11-yl]ethanone

C20H19NO4 (337.1314)


   

1-{7-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-11-yl}ethanone

1-{7-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-11-yl}ethanone

C20H19NO4 (337.1314)


   

(1r,24s)-24-methyl-5,7,17,19-tetraoxa-13-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁵,²³.0¹⁶,²⁰]tetracosa-2,4(8),9,15,20,22-hexaene

(1r,24s)-24-methyl-5,7,17,19-tetraoxa-13-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁵,²³.0¹⁶,²⁰]tetracosa-2,4(8),9,15,20,22-hexaene

C20H19NO4 (337.1314)


   

18,19-dimethoxy-13-methyl-5,7-dioxa-13-azapentacyclo[10.7.1.0²,¹⁰.0⁴,⁸.0¹⁶,²⁰]icosa-1(20),2(10),3,8,11,16,18-heptaene

18,19-dimethoxy-13-methyl-5,7-dioxa-13-azapentacyclo[10.7.1.0²,¹⁰.0⁴,⁸.0¹⁶,²⁰]icosa-1(20),2(10),3,8,11,16,18-heptaene

C20H19NO4 (337.1314)


   

16-hydroxy-14,15-dimethoxy-8,8-dimethyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1,3,6,9(17),11,13,15-heptaen-5-one

16-hydroxy-14,15-dimethoxy-8,8-dimethyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1,3,6,9(17),11,13,15-heptaen-5-one

C20H19NO4 (337.1314)


   

(2e)-3-methanesulfonyl-n-(2-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}ethyl)prop-2-enimidic acid

(2e)-3-methanesulfonyl-n-(2-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}ethyl)prop-2-enimidic acid

C17H23NO4S (337.1348)


   

2,3,11-trimethoxy-7,8-dihydro-6-azatetraphen-10-one

2,3,11-trimethoxy-7,8-dihydro-6-azatetraphen-10-one

C20H19NO4 (337.1314)


   

[(3r)-9-hydroxy-3,5-dimethyl-11h-pyrano[3,2-a]carbazol-3-yl]methyl acetate

[(3r)-9-hydroxy-3,5-dimethyl-11h-pyrano[3,2-a]carbazol-3-yl]methyl acetate

C20H19NO4 (337.1314)


   

5,7-dihydroxy-2-phenyl-6-(piperidin-2-yl)chromen-4-one

5,7-dihydroxy-2-phenyl-6-(piperidin-2-yl)chromen-4-one

C20H19NO4 (337.1314)


   

1-(1-amino-2-{[2-amino-1-hydroxy-2-(4-oxopyridin-1-yl)ethyl](hydroxy)amino}-2-hydroxyethyl)pyridin-4-one

1-(1-amino-2-{[2-amino-1-hydroxy-2-(4-oxopyridin-1-yl)ethyl](hydroxy)amino}-2-hydroxyethyl)pyridin-4-one

C14H19N5O5 (337.1386)


   

3,10,11-trimethoxy-7,8-dihydro-6-azatetraphen-2-one

3,10,11-trimethoxy-7,8-dihydro-6-azatetraphen-2-one

C20H19NO4 (337.1314)


   

3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-8-azabicyclo[3.2.1]octane-1,2,6-triol

3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-8-azabicyclo[3.2.1]octane-1,2,6-triol

C13H23NO9 (337.1373)


   

3,10,11-trimethoxy-7,8-dihydro-6-azatetraphen-4-one

3,10,11-trimethoxy-7,8-dihydro-6-azatetraphen-4-one

C20H19NO4 (337.1314)